Interview: Ignasi Biosca, CEO, Reig Jofre, Spain
Prior to joining the family business, Ignasi Biosca spent his career working in online media and internet advertising. Upon becoming CEO of Reig Jofre in 2007, he quickly sought to…
The Royal Academy of Medicine began its history in the first third of the eighteenth century in the midst of a gathering in the pharmacy of José Hortega, under the Enlightenment movement. In July 1733 it became a grouping of professionals, initially titled “Tertulia Médico-Chymica-Phisica” and later “Tertulia Médica Matritense”.
It received the royal sanction from Felipe V in September 18, 1734, following approval of its statutes, which became the Tertulia in Academia.
It was reorganized by Royal Decree of April 28, 1861, “to promote the progress of Spanish medicine, publish its story literature, forming the medical geography and a technological dictionary of medicine.”
It uses as emblem a shield that represents the allegory of Archimedes, which states that by using many small mirrors arranged in a dish and using the sun’s rays, set the Roman fleet on fire.
The academic medals bear a midwife allegory symbolizing medicine and the legend “Ars cum natura ad salutem conspirans”.
Today, the Royal Academy of Medicine holds public scientific sessions every Tuesday during the course, in which two scholars set scientific issues, takeover sessions, opening and closing of the course, special sessions, etc.
Regarding publications, the journal published quarterly RANM Annals, which includes the lectures delivered at scientific sessions, news bulletins, an activity newsletter and monographs, etc…
The tasks and current projects of the Royal Academy include: the Dictionary of Medical Terms, the announcement and awarding of prizes, computerization of its bibliography, etc.
It consists of fifty Academic Fellows and Honor Scholars, Corresponding National and Foreign Fees and Medals of Honor.
Its current President, since 2012, is Prof. D. Joaquin Poch Broto.
CONTACT DETAILS
Calle Arrieta nº12
28013 Madrid
Tlf.: +34 91 547 03 18
Fax: +34 91 547 03 20
Prior to joining the family business, Ignasi Biosca spent his career working in online media and internet advertising. Upon becoming CEO of Reig Jofre in 2007, he quickly sought to…
Xavi Martí, managing director of Lundbeck Spain, discusses how the affiliate responds to the challenge of social stigma surrounding mental diseases and new strategies to open up the company’s portfolio…
Key to improve the Chilean health care system is providing continuous training programs and sharing knowledge with healthcare professionals”, explains Cécile Bassereau, Managing Director B Braun Chile. B. Braun has…
As a leading company in the hospital sector, Roche Spain undoubtedly felt the effects of austerity measures imposed by Spanish health authorities since 2010. Nevertheless, the affiliate has remained in…
Bertil Lindmark, Almirall’s chief scientific officer, discusses the state of R&D in Spain today and outlines the key strategies the company is taking to provide valuable medicines and cutting-edge technologies…
Owned completely by the LEO Foundation, LEO Pharma is an extremely patient-centric company focused primarily in the dermatology area. Kristian Hart-Hansen, general manager of LEO Pharma Spain, discusses the challenges…
In a market dogged by price cuts and changes in regulations, the challenges for blood plasma companies have become graver than ever. In spite of these challenges, CSL Behring remains…
In a market dogged by price cuts and changes in regulations, the challenges for blood plasma companies have become graver than ever. In spite of these challenges, CSL Behring remains…
Raúl Díaz-Varela is the CEO of Kern Pharma and has served as president of Spain’s generics association AESEG since 2008. He speaks to us about the challenges facing generic companies,…
Jesús Sobrino was appointed general manager of UCB Iberia in 2010, at the same time the pharma market began to seriously contract in Spain. Sobrino discusses adapting to these changes…
PharmaBoardroom first interviewed Erik Lommerde as general manager of Novo Nordisk Netherlands four years ago. In his new role as general manager of Novo Nordisk Spain & Portugal, he discusses…
Invest in Catalonia discuss the Spanish region’s track record when it comes to the pharmaceutical and biotech sectors, where investment is going today in the region, and the factors that…
See our Cookie Privacy Policy Here